1.88% 0.14

Regencell Bioscience Holdings Ltd (RGC)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit Dividendenhistorie

Finanzdaten der Regencell Bioscience Holdings Ltd-Aktie (RGC)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	20.34% 861.60	716.00	764.20	821.20	812.60
Operating Expenses	11.16% 770.90	693.50	705.20	721.70	717.60
Benefits Costs and Expenses	14.51% 792.40	692.00	722.60	742.10	728.90
Costs And Expenses	11.16% 770.90	693.50	705.20	721.70	717.60
Other Operating Income/Expenses	60.13% 76.70	47.90	51.60	48.50	70.60
Operating Income/Loss	303.11% 90.70	22.50	59.00	99.50	95.00
Nonoperating Income/Loss	1,533% -21.50	1.50	-17.40	-20.40	-11.30
Income/Loss Before Equity Method Investments	217.74% 59.10	18.60	35.00	77.10	73.10
Income/Loss From Equity Method Investments	87.04% 10.10	5.40	6.60	2.00	10.60
Income/Loss From Continuing Operations Before Tax	188.33% 69.20	24.00	41.60	79.10	83.70
Income Tax Expense/Benefit, Deferred	98.57% 0.10	7.00	-3.20	-4.50	5.30
Income Tax Expense/Benefit	219.84% 40.30	12.60	18.00	30.70	29.80
Income/Loss From Continuing Operations After Tax	153.51% 28.90	11.40	23.60	48.40	53.90
Net Income/Loss	153.51% 28.90	11.40	23.60	48.40	53.90
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	100.00% 0.004	156.35	156.35	156.29	-
Diluted Average Shares	99.98% 0.031	156.88	156.94	157.04	0.045
Basic Earnings Per Share	171.43% 0.19	0.07	0.15	0.31	0.34
Diluted Earnings Per Share	171.43% 0.19	0.07	0.15	0.31	0.35
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

AMLX

$28.17

0.46%

INDV

$34.28

1.25%

LQDA

$46.54

2.42%

BHC

$6.6001

4.60%

SUPN

$40.37

1.45%